SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SYNCOM FORMULATIONS (INDIA) LT

BSE: 524470 29 Jun 2025
Healthcare
₹ 19
Syncom Formulations (India) Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SYNCOM FORMULATIONS (INDIA) LT - Share Price & Details

Market Cap
₹1,801
High /Low
27.9 / 12.3
Stock P/E
36.4
Book Value
₹3.64
Dividend Yield
0.0
ROCE
18.8
ROE
₹15.7
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹25.2
Debt
4.58
CMP / FCF
-504.0
Debt to equity
₹0.01
NP Ann
49.4
High price all time
27.9
Piotroski score
₹8.0
Graham Number
6.56
No. Eq. Shares
94.0
Net CF
₹-62.7
Net profit
49.4
Price to book value
5.26
Interest Coverage
₹77.2
Low price all time
0.32
Industry PE
32.0
Reserves
₹248
Free Cash Flow
₹13.5

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
SYNCOM FORMULATIONS (INDIA) LT1553.66175.021484.630.161,80136.4
BLISS GVS PHARMA LTD.1653.63114.521560.021.07166119.7
Bajaj Healthcare LimitedNANANANA164138.2

Peer Comparison Chart


About SYNCOM FORMULATIONS (INDIA) LT

Syncom Formulations (India) Ltd., with Security Code 524470, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Are Robust Financials Driving The Recent Rally In Syncom Formulations (India) Limited's (NSE:SYNCOMF) Stock?

(19 Jun 2025)
Most readers would already be aware that Syncom Formulations (India)'s (NSE:SYNCOMF) stock increased significantly by...
Read more →

Syncom Formulations India Ltd commissions solar rooftop project

(13 Jun 2025)
After trial for 15-20 days, Solar Rooftop Project of 435KWp DC (325 KW AC) over Roof Top at Manufacturing Plants located at Plot No.
Read more →

Syncom Formulations (India) Ltd Reports Stellar Growth in Q4 and FY 2024-25 Results; Profit After Tax Surges by 139%

(06 Jun 2025)
Syncom Formulations (India) Limited announced a stellar financial performance for Q4 and FY2025, driven by significant revenue and profit...
Read more →

Syncom Formulations posts 139% profit surge in Q4 FY25

(04 Jun 2025)
Mumbai, June 4: Syncom Formulations (India) Ltd reported a 139% rise in net profit for the fourth quarter of FY25, with profit after tax...
Read more →

Syncom Formulations (India) Limited Reported Its Excellent Performance For 4th Quarter

(02 Jun 2025)
Mumbai (Maharashtra) [India], June 2: Syncom Formulation ( India ) Ltd , a Speciality Pharmaceutical Formulation company Today reported its...
Read more →

Syncom Formulations (India) Limited Reported Its Excellent Performance For 4th Quarter And Year Ended 31st March 25

(02 Jun 2025)
Mumbai (Maharashtra)...
Read more →